history
Overview & History
Overviwe
NAME
CUBEBIO Co., Ltd.
BUSINESS
Research and development of medicine and pharmacy,
Distribution of drug medicines and medical devices
Distribution of drug medicines and medical devices
MAIN PRODUCTS
Cancer Diagnostic Rapid Kit, ELISA Kit, Self-Diagnostic Device
ADDRESS
8F Shinhan Life Bldg, Digital-ro 10-gil 9, Geumcheon-gu, Seoul, Korea
CAPITAL
16 billion KRW (US$15 million)
R & D PRODUCTS
Cancer Biomarker
Single- & multi-Cancer Biomarker
Specimen
Urine, Blood
Single- & multi-Cancer Biomarker
Specimen
Urine, Blood
History
2011
11 Established CUBEBIO Co., Ltd.2014
10 Attracted investments worth 3 billionKRW from Development Bank CB
2015
03 Certified as a company-affiliatedresearch center
04 Certified as a venture business
2016
05 Completed merging with CUBEBIO2017
10 Gained the manufacturing approvalfor medical devices
Earned the export approval for medical
devices (Korean Ministry of Food
and Drug Safety)
2018
12 Gained approval from theFDA of the Philippines
2019
01 Awarded the Korean Patent Grand Prize 02 Obtained the approval for sales of Class IIin vitro diagnostics from the Chinese FDA
(沈阳阿一生物科技有限公司) Signed a contract with Yongchenghanyuan
(永成汉源), a China/Hong Kong-based
large asset management company,
with regards to investments and
Nasdaq listings 04 Signed a contract with Samsung
Securities Co., Ltd., as a lead underwriter 07 The signing of Patron partnership
agreement as well as 'CUBEBIO-UICC
Cancer Early Detection and Self-Diagnosis'
program agreement with the Union for
International Cancer Control (UICC) Awarded the 2019 Moneytoday Grand Prize
for Innovative Technology in the field of
innovative technology
'Cancer Self-Diagnostic Device' 09 Signed a contract for the export of
cancer self-diagnostic devices
in the Russian Federation and CIS countries .
Awarded the Global Top Technology
Grand Prize at the 2019 Moneytoday
World Class Small-Mighty Enterprise Award
10 Participation in the UICC-led
World Cancer Leaders' Summit in
Kazakhstan by invitation only